Defending Nader is hard but I have always had that soft

New Post Public Reply Private Reply Replies (3) Message Board
Goosebumps Riztheinvestor #105409
1,097
Defending Nader is hard but I have always had that soft spot for Nader. I feel Nader is a genuinely good guy with a big heart and wants to badly get us an approval. I feel that he has based his whole life on this next approval of any kind… be it a EUA or equivalent. He can’t wait for it to happen. He NEEDS this validation personally. There would be no more dedication from any person that could or would replace him. We have a man with the upmost dedication in the right position at the right time.

I remember Nader saying after an approval he would take a limited roll and step down. My guess is just a BOD position as we search for that CEO that can build our company into a pharmaceutical company. A top CEO that has been there and knows how to grow our company into the largest pharmaceutical company we can become. This is my dream… as investors we have dreams… this is the top dream for return on our money.

Nader set us up for success with the partnership of Biomm and the CRO in Albert Einstein hospitals performing our trials. Nader has done his job. We now wait for results. Will we have mistakes at this point going forward? I don’t believe we will because Cytodyn is in a just watching mode. We wait and watch and reap the benefit of our current partnerships in Brazil. Biomm will take the Albert Einstein trial information and analyze it to death. Remember they had 20 people on each conference call while they developed the protocol for these trials. Biomm is committed and will be our knight in shining armor. They will get us our first approval.

I have been flipping the magic 8 ball over and over asking the right questions and getting the right answers. “ It will happen “ is my favorite answer. lol. I wonder how many people that read this will even know about the magic 8 ball and it’s crystal ball like predicted answers? lol

I make light of this but in reality we are in the best position we have ever been in looking at an approval. We have an experienced pharmaceutical in Biomm that can get the job done. We have a great CRO finally that will get it done in a timely manner. We have all the cards lined up for success and it’s just a little bit of time before we get the satisfaction we all have been waiting for. If leronlimab shows as we expect it to… we don’t have any issues any longer. We have substantial revenue to fund the other trials and buy more Leronlimab. Our revenue will set us free to help the world. The dominos of success will start the long road of falling into place just as we expected it to. We will have achieved our first of many approvals.

#letsgoBiomm

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Next Bridge Hydrocarbons' Call for Presidential Intervention

Updated Category News Views 48

Trump's New Team: A Hope for Shareholder Relief? Picture the scene—Next Bridge Hydrocarbons, caught in the depths of shareholder unrest over the unresolved MMTLP fiasco, is looking to the top for answers. With a fresh face, Stephen Miller, stepping in as the White House Chief of Staff, there's a new angle at play. They're knocking on the doors of the Trump...

Continue Reading
New Leadership at Reactive Tech: Claudio Facchin Steps In

Updated Category News Views 154

Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...

Continue Reading
Innovative Eyewear Powers Ahead with 51% Revenue Boost

Updated Category News Views 64

Big Gains and Bigger Moves Ahead Here's a bit of sunshine for your investment portfolio: Innovative Eyewear's third-quarter results are packing quite the punch, showing a strong 51% uptick in revenue year-over-year. If you've got a stake in NASDAQ:LUCY, pay close attention. This ain't just a flash in the pan; it's a consistent rise, marking their 13th consecutive quarter...

Continue Reading
Why Retaining Wall Drainage Can’t Be an Afterthought

Updated Category News Views 47

The overlooked hero in wall longevity People might think building a retaining wall is just stacking stones or pouring concrete, but that's only part of the story. According to Justin Hundich, our go-to guy on landscape and drainage matters, there's way more at play than meets the eye. If you ignore drainage, you're steaming toward disaster, my friend—no two ways about...

Continue Reading
Outer Spaces Unveils OS1 at Major Energy Expo

Updated Category News Views 105

Introduction to the Future of Solar Living Just when you thought you'd seen it all, along comes Outer Spaces with their OS1—a solar pavilion and battery deck that looks at residential energy with fresh eyes. Debuting at the RE+ 2026 in Las Vegas, this isn't just another gizmo. This is about bringing solar power to your backyard without making your roof look like it...

Continue Reading
OpenHear BM420: CES 2027 Honoree for Accessibility

Updated Category News Views 58

Shokz's Big Leap With OpenHear BM420 Alright, this recognition for Shokz comes out of the left field for anyone not keeping an eye on their trajectory lately. From headphones to hearing aids—Shokz takes a genuine shot at making life easier for folks struggling with hearing issues. The CES 2027 Innovation Award for their OpenHear BM420 shows the tech's real potential in...

Continue Reading
Illinois Ban Risks Boosting Illicit THC Drink Sales

Updated Category News Views 61

Illinois Cranks Up the Heat on Low-Dose THC Drinks Illinois, you've really done it this time. When it comes to low-dose THC beverages, the state is setting up shop for illicit sellers by going harsher than federal standards. On November 12, these drinks, which have a loyal following, will be off the shelves—thanks to a reclassification that lumps them in with more...

Continue Reading
Krispy Kreme Faces Legal Heat Post McDonald's Exit

Updated Category News Views 48

Krispy Kreme's Sugar-Coated Trouble Ah, Krispy Kreme, where donuts and legal woes seem to go hand in hand these days. Dropping donuts might be a morning mishap, but dropping a stock by 37%? Now that’s a disaster, especially when folks like Schubert Jonckheer & Kolbe smell a rat in the kitchen. Fresh Out of the Baker's Oven: Lawsuit Updates On August 26, 2026, a...

Continue Reading
Rainmaker's Cloud Seeding Milestone: Big Leap or Hype?

Updated Category News Views 34

Pioneering Cloud Seeding: Rainmaker's Big Talk Mornings like this, I find myself wondering if we're still all buying snake oil—or if the future just landed in our laps. Rainmaker Technology Corporation just dropped what might be a game-changer or a grand illusion for those of us with a finger on the pulse of water tech. Their study in 'Atmosphere' paints a picture of...

Continue Reading
ALP's Bold NYC Pop-Up: A Gamble or Genius Move?

Updated Category News Views 20

ALP Swings Big in the Big Apple Here's a move that's about as loud as blaring your TV at midnight — ALP, the nicotine pouch brand that’s been taking quiet corners of rural America by storm, is barging into New York City with a brazen pop-up and a parade of marketing antics. Think of it as taking the Wild West and plunking it down in the urban jungle. They're...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Strategies: Invivyd's Future in Biopharmaceuticals

Updated Category News Views 106

Invivyd's Upcoming Financial Results Conference Call Invivyd, Inc. (Nasdaq: IVVD), a pioneering leader in the biopharmaceutical industry, has exciting developments lined up for their investors. On an upcoming Thursday morning, the company will host a conference call aimed at discussing their financial performance and business strategies. This communication will take place...

Continue Reading
How Young Chinese Artists Merge Tradition with Trendy Culture

Updated Category News Views 194

The emergence of young Chinese artists reshaped the cultural scene by fusing traditional elements with contemporary expressions. This isn’t just a passing phase; it’s a full-blown movement where the youth aren’t merely adopting global trends but redefining them with their unique insights. Take Liu Qingyi, for example. The 19-year-old breakdancer dazzled audiences at...

Continue Reading
STRATA Skin Sciences Announces Participation in Global Conference

Updated Category News Views 106

STRATA Skin Sciences to Attend D. Boral Capital Conference STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a prominent medical technology company, is set to participate in the D. Boral Capital Inaugural Global Conference. This significant event will be held in a leading location, offering the perfect platform for STRATA to showcase its...

Continue Reading
Medecision and Sendero Health Plans Unite to Transform Care

Updated Category News Views 190

Medecision Partners with Sendero Health Plans for Health Improvement Medecision, a leader in clinical data solutions, has announced an exciting partnership with Sendero Health Plans, a nonprofit healthcare organization. Together, they aim to significantly enhance health outcomes within the communities of Central Texas. Commitment to Quality Care Sendero Health Plans is...

Continue Reading
Julia Vorholt Honored with Prestigious Biotechnology Award

Updated Category News Views 182

Julia Vorholt's Groundbreaking Research Professor Julia Vorholt has made significant contributions to our understanding of plant health through her pioneering research on plant microbiomes. Her work reveals that just like humans rely on beneficial gut bacteria, plants too harbor communities of microorganisms that play a vital role in their development. This revelation...

Continue Reading